Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Diabetes Connections | Type 1 Diabetes

“What are you most looking forward to?” A T1D New Year conversation with Gary Scheiner, MS, CDCES

02 Jan 2024

Description

Happy New Year! It’s our first episode of 2024 so let’s talk about what this year could bring. I’m doing some predictions with the wonderful Gary Scheiner, MS, CDCES. Gary is the founder of Integrated Diabetes Services and has been named Educator of the Year by the ADA. He’s the author of Think Like a Pancreas and has launched a podcast with the same name. We’ll take a quick look back at 2023, find out what he’s most looking forward to in 2024 and what else we might expect in the months to come. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. 2023 prediction episode here 2022 prediction episode here Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: [email protected]    

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.